Sciatica
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Adults with chronic sciatica; moderate or severe leg pain intensity; 18-65 years old; both sexes
Exclusion criteria
Exclusion criteria: Participants in treatment due to sciatica; participants planning to undergo any other procedures for sciatica treatment in the study period; present known or signs of serious spinal pathology; history of abdominal, lumbar, or lower limb surgery in the past year; rheumatologic disease in the acute inflammatory phase; if they are receiving disability compensation due to LBP; pregnant or puerperal women; self-reported psychiatric diagnosis; history of cancer; and cancer-related pain
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| We will evaluate leg pain intensity and functional limitation of patients with chronic sciatica. It is expected that patients with chronic sciatica allocated to the neural management group added advice to remain active will have a statistically significant reduction in pain intensity and improved functionality after the treatment period (short, medium and long term) in a way superior to patients with chronic sciatica allocated in the group of only advice to remain active | — |
Secondary
| Measure | Time frame |
|---|---|
| We will evaluate neuropathic symptoms, sciatic neurodynamic, pain modulation, and psychosocial factors. It is expected that patients included in the experimental group will improve the sciatic neurodynamic after the treatment period in a superior way compared to the control group. The analysis of the participant's baseline characteristics will provide information on the most relevant aspects of the participant's self-reported pain perception. In addition, the analysis of mediators will make it possible to identify potential factors that explain the clinical improvement of the participant with chronic sciatica submitted to the study interventions. | — |
Countries
Brazil
Contacts
;